Abu Dhabi Diabetes and Obesity Study

Sponsor
Imperial College London Diabetes Centre (Other)
Overall Status
Completed
CT.gov ID
NCT01843959
Collaborator
(none)
2,130
Enrollment
1
Location
49
Duration (Months)
43.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

A cross-sectional study investigating the aetiology, mechanisms and associated complications contributing to obesity and diabetes within the UAE population. The study will be carried out in two main sample populations; children and adults, and characterized by the occurrence of obesity and diabetes. The main samples will then be divided into a subgroup for metabolomic analysis. Patients will be recruited from the Imperial College London Diabetes Centre. The study is aimed at elucidating the various factors that have an impact or may influence obesity and diabetes in the Emirati population.

Condition or DiseaseIntervention/TreatmentPhase

    Detailed Description

    Obesity and Type 2 diabetes (T2DM) have been regarded as global epidemics in developed countries and more recently in developing nations. Obesity (a T2DM risk factor) and T2DM present significant health risks as individual diseases and substantial risks in individuals with both complications (Deepa Nath, 2006). The UAE and USA have a similar prevalence of obesity, 36% and 35.7% respectively. Interestingly, the percentage of the population with T2DM between the two groups differs significantly, 25% and 8.7% respectively. The rate of T2DM in the Emirati population is 2.9 fold higher than in the US. This suggests an altered inter relationship between obesity and T2DM. One hypothesis that could explain such a variation is differences in body metabolism and central adiposity between the two populations. This will be assessed by measuring cardiometabolic risk factors, central adiposity and metabolomics. Analysis of the metabolomic profiles may help define the risk factors associated with diabetes and differences in metabolic activity between various ethnicities.

    Another area of ample interest is the advanced glycation end-products (AGEs) metabolic pathways (Pietropaoli D, 2012). AGEs are formed at an increased rate in diabetes and have a number of detrimental effects such as retinopathy, nephropathy and atherosclerosis (Melpomeni Peppa, 2003). As such, determining the core mechanisms that result in metabolic and cardiovascular dysfunction will aid in identifying and developing therapeutic targets, which may in turn alleviate the deleterious effects of respective disorders such as diabetes.

    The aetiology of diabetes is complex. However, adenovirus 36 has been shown to play a significant role in obesity and diabetes. As such, analysis of ADV-36 occurrence within the Emirati population may provide insight into a novel obesity and diabetes risk factor and could further clarify the relationship between obesity and T2DM.

    This study may provide evidence that clarifies how obesity can result in T2DM, and why this occurrence is more predominant in the Emirati population. In addition, the assessment of AGEs within the population, ranging from people with diabetes and obesity to healthy individual, may provide insight into potential therapeutic targets, thereby improving overall heath in the population. Finally, the data may improve our knowledge of new risk factors such as ADV-36 and their subsequent effects on diabetes.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    2130 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Abu Dhabi Diabetes and Obesity Study (ADOS) - A Study on the Aetiology and Associated Risk Factors of Patients With Obesity/Diabetes Within the Emirati Population.
    Study Start Date :
    Mar 1, 2013
    Actual Primary Completion Date :
    Apr 1, 2017
    Actual Study Completion Date :
    Apr 1, 2017

    Arms and Interventions

    ArmIntervention/Treatment
    Emirati Population

    The individuals enrolled in this study will be divided into children (5-16 years of age) and adults (above 18). The groups will be further divided into BMI categories and glucose tolerance groups. * Group 1: Underweight (adjusted BMI <10th percentile) and no diabetes Group 2: Normal weight (adjusted BMI 10th to 84.9th percentile) and no diabetes Group 3: Overweight or obese children (adjusted BMI >= 85th percentile) and no diabetes Group 4: Normal weight (adjusted BMI 10th to 84.9th percentile) and T1DM Group 5: Overweight or obese children (adjusted BMI ≥ 85th percentile) and T1DM Group 6: Normal weight (adjusted BMI 10th to 84.9th percentile) and T2DM Group 7: Overweight or obese children (adjusted BMI ≥ 85th percentile) and T2DM

    Outcome Measures

    Primary Outcome Measures

    1. Percentage of the population in the U.A.E that are positive for adenovirus -36, specifically in children. [One year]

      The initial aim of the study is to measure the prevalence of adenovirus 36 in the Emirati population.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • All patients are eligible to participate in the study
    Exclusion Criteria:
    • Under 5 years of age

    Contacts and Locations

    Locations

    SiteCityStateCountryPostal Code
    1Imperial College London Diabetes CentreAbu DhabiUnited Arab Emirates48338

    Sponsors and Collaborators

    • Imperial College London Diabetes Centre

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Dr Nader Lessan, MD, Consultant Endocrinologist, Imperial College London Diabetes Centre
    ClinicalTrials.gov Identifier:
    NCT01843959
    Other Study ID Numbers:
    • IREC008
    First Posted:
    May 1, 2013
    Last Update Posted:
    Oct 13, 2021
    Last Verified:
    Oct 1, 2021
    Keywords provided by Dr Nader Lessan, MD, Consultant Endocrinologist, Imperial College London Diabetes Centre
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 13, 2021